Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder
# Purpose of Review Attention deficit hyperactivity disorder (ADHD) is a widely diagnosed neurodevelopmental disorder giving rise to symptoms of hyperactivity, impulsivity, and inattentiveness that can impair daily functioning. Stimulants, such as methylphenidate and amphetamines, are the mainstay...
Saved in:
| Main Authors: | Christopher L Robinson, Katelyn Parker, Saurabh Kataria, Evan Downs, Rajesh Supra, Alan D. Kaye, Omar Viswanath, Ivan Urits |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Medical Publishing
2022-09-01
|
| Series: | Health Psychology Research |
| Online Access: | https://doi.org/10.52965/001c.38360 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Daridorexant for the Treatment of Insomnia
by: Christopher L Robinson, et al.
Published: (2022-08-01) -
Prenatal Acetaminophen Exposure and its Associated Risk for Attention Deficit Hyperactivity Disorder
by: Noah J. Spillers, et al.
Published: (2024-11-01) -
Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01) -
Viloxazine versus imipramine in the treatment of enuresis
by: M Yurdakök, et al.
Published: (1987-10-01) -
A Need for Further Education on Buprenorphine in Pain Medicine
by: Jamal Hasoon, et al.
Published: (2023-05-01)